Benjamin Graham · Defensive deep-value investing
Is Royalty Pharma plc (RPRX) a Benjamin Graham Stock?
Meets 3/7 Graham criteria, classic deep-value candidate.
82/100
Fits
3/7 criteria passed
Benjamin Graham's Criteria, Applied to RPRX
P/E ≤ 15
key27.6x
P/B ≤ 1.5
key3.3x
Current ratio ≥ 2
2.7x
Debt / Equity ≤ 1
1.3x
How RPRX Scores on Other Strategies
Live Financial Snapshot
Market cap
$38.1B
P/E (TTM)
27.6x
ROIC (TTM)
8.43%
Gross margin
99.95%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is RPRX's Benjamin Graham fit score?
RPRX scores 82/100 on our Benjamin Graham fit engine. Meets 3/7 Graham criteria, classic deep-value candidate.
Does Benjamin Graham actually own RPRX?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends RPRX.
How often is this score updated?
RPRX's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends RPRX.
